News | July 01, 2007

Study Validates Savings Generated by MedSolutions’ Radiology Management Programs

July 2, 2007 - Believed to be the first study to demonstrate cost savings for radiology management with statistical analyses, a report by a Milliman team recently released by MedSolutions Inc. shows per member per month (PMPM) savings for a program that managed three high technology diagnostic imaging services covered by the MedSolutions: contract-computerized axial tomography (CAT), magnetic resonance imaging (MRI) and positron emission tomography (PET).

“The reductions compared to trend generated for the HMO after MedSolutions’ involvement are impressive, especially in light of double-digit inflation for high-tech imaging studies,” says Kathryn Fitch, RN, MEd and principal at Milliman. “We estimate that, compared to costs based on historical trends, the HMO’s allowed PMPM experience was lower during the MedSolutions management period by 30 percent during 2Q05-4Q05 and 42 percent during 1Q06-3Q06.”

Industry experts attribute about 10 percent of the total commercial medical spend to radiology, and the growth in volume has been significant. According to the Blue Cross Blue Shield Association (2006), over the course of three years (1999 to 2001) the number of MRI scans rose by more than 45 percent. Diagnostic imaging services paid under the Medicare Physician fee schedule grew more rapidly than any other physician category between 1999 and 2003, at 45 percent more than twice the growth for all physician services. The primary drivers of trends in imaging costs include increased inappropriate and redundant use of imaging, increased sales and installation of imaging scanners, development of new high-tech imaging and direct marketing to consumers.

For more information: www.medsolutions.com, www.milliman.com

Related Content

Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
Imaging agent helps predict success of lung cancer therapy
News | Oncology Diagnostics | March 08, 2018
March 8, 2018 – Doctors contemplating the best therapy for...
Overlay Init